Member Info for lukehere

If you are lucky enough to own any shares in Stilo International then the MMs urgently require them. They have been bidding at just below mid price for some days now and it could be that their earlier supplier has drawn stumps. All very encouraging for holders. As Breton59 says, "Sit tight",and wait for the real action to begin !

If the MMs were not kept being supplied with stock,eg a further 205,000 shares this afternoon @ 4.25,then imo the SP would be much higher Breton59. With record profits a distinct probability for 2015,plus a potential engagement at enterprise level with IBM and not forgetting AuthorBridge,the potential for Stilo to surprise the market is no secret to the few who have this micro cap on their radar.

Even though there has been some profit taking today,it has remained a difficult market for buyersof STL.. The newsflow over the next few months could have a dramatic effect on the SP,imo

Thanks for that information,testpack3. Did you have a buy order in place throughout the day,in order to secure the purchase; for STL shares had proved difficult to obtain earlier .

Stilo enters the last 3 months of its trading year. AuthorBridge is about to be launched and much increased profitability is assured. Results due in days,with news on the IBM pilot on its way. Very exiting times then ! Someone else thinks so too, for one can sell several hundred thousand shares at a premium this morning.

A black cross on a red background to denote corrosive formulations. ------------------------------------------------------------------------ "And the cost of that(reformulation) is likely to be passed on to the consumer,” warned Dr Trevor Francis of Byotrol which makes antibacterial products for Boots, Tesco. “The European Union has decided which products are dangerous, often based on dubious trials which companies cannot afford to re-run to see if they would get the same results. “You could see a lot of smaller companies going out of business because of the new rules.” The EU Biocides Regulation covers disinfectants, pest control products and preservatives which means that many products fall under the new diktat. The European Union has also banned the disinfectant chemical polyhexamethylene biguanide (PHMB) which is used extensively in disinfectants in food manufacturing industry, hospitals and is even present in Boots own hand sanitizer. Without it, companies fear that cases of norovirus, listeria and campylobacter will jump. Byotrol is currently trying to come up with a new formula for Boots hand sanitizer that will comply with regulations, but fear it will not be as affective."

Copied from the ADVFN thread. "Stilo International's Interim Results,due in about 5/6 weeks, could well signal the serious uplift in revenues/EBITDA which we know lies ahead. The header alludes to bullish statements made this year by the BOD. Additionally, Stilo has announced the receipt of an order value US$765,000 from a major semi-conductor manufacturer for Stilo Migrate, its cloud content conversion service.The order is spread over three years, and is planned for delivery in June 2015. It is worth US$265,000 in the current year to 31 December 2015. As revenues in the second half of 2014(excluding software maintenance)amounted to just £279k,the above contract, on its own, would serve to almost double that 2014 figure. Add to this the "raft" of other contracts for Migrate allied to a maiden contribution from AuthorBridge and the potential for eye catching increases in profitabality moves up a gear.The "icing on the cake",according to CEO Les Burnham will be new contracts for Omnimark. We are lucky to have such a reliable,focused,low cost yet alpha grade CEO. His projections for Stilo over the past six years have been remarkable in their accuracy .The fact that he is now forecasting a very exciting future for STL should therefore be acted upon. He is well supported by an able and adroit Chairman who steadfastly continues to decline any remuneration or expenses! Should Stilo announce that IBM have satisfactorily concluded the AuthorBridge pilot and gone live at enterprise level then surely STL's days as a micro cap must be numbered. In the meantime the company remains ungeared,boasts over £1million on deposit and pays us a worthwhile and progressive dividend. Beyond all this though are the ongoing enhancements to Stilo's proprietary software which the BOD believe will enable it to more than compete in terms of performance and pricing with those currently dominant in the market place,thus enabling STL's corporate performance to be propelled way beyond its current parameters. No wonder Chairman David Ashman continues to buy Stilo shares,having purchased a further 7% of the equity in 2015."

The BOD might just preparing the ground for a significant fundraising.

Having seen so many punters lose 95% and more of their stake through investing in this poisonous outfit ; today's recommendation from rivaldo to join in the "fun" must surely be an unfortunate jest.. Imo a 死猫反弹 is the best anyone can hope for. 遗忘 seems more likely.

Extracted from the STL 2014 accounts :- If the US$ had strengthened by 10% against the Canadian $, post-tax profit would have been £31,000 higher ... The US $ continues to strengthen against the C$. Plus of course any impending currency influenced profit increases will be additionally leveraged as revenues rise. 1 US Dollar today equals 1.27 Canadian Dollar. The average rate in 2014 was 1.10. No wonder the Stilo share price is edging upwards toward a multi year high,for here is a company poised to deliver impressive growth.

There is a really tight spread at the moment with 50K shares available to buy @ 3.34,whilst the same amount can be sold @3.25 pence.The last two large transactions have both been buys.. STILO remains on course to post record profits,whilst the news flow could be singularly positive should any news on the AuthorBridge pilot emerge. A hugely exciting investment opportunity is presenting itself,imo.

All must be proceeding as planned for the Stilo Chairman to avail himself of another 5% of the STL equity. New revenues from AuthorBridge,seriously increasing revenues from Migrate and very probably Omnimark reversing its recent decline,point towards a particularly bullish set of interim results. Should there be positive news on the AB/IBM engagement then the SP could well double or more,prior to really starting to motor. Exciting,imo.

Every one has their own strategy for investing.I treat it a bit like getting married.Fully explore the alternatives and once the field has been honed down to just one,do your level best to ascertain if there might be any hidden pitfalls..........................then go for it. Stilo, to some, is boring and dead in the water.That is why we don't all chase the same woman/share. The time is coming however when STL will slip off its gown to reveal her attributes. Then everyone will want a piece of the action !

I hold 2% of the STL equity. I have said on several occasions that I consider Stilo to be the most interesting company on AIM and beyond. Immerse yourself in recent information regarding the Company---- Directors buying/disruptive new technology,micro cap status,yet with no debt and £1million = cash in the bank,IBM about to engage STL at enterprise level,profitable in a minor way for the past 5 years,pays an increasing dividend,has a Chairman who draws mno salary or expenses and has technology relevant to a burgeoning market place,and is well regarded in its field(to name but a few plus points). Don't take my word for it though,DYOR.

I mirror your status Breton59. Investing in AIM has proven far superior to working. I avoid buying speculative situations,pump and dump,oilers and miners,together with larger sluggish corporates . STL has everything an investor like myself might look for in spades. Wiki describes Omnimark,Stilo's core technology,thus, "OmniMark is well known for its use of a streaming architecture which makes it particularly efficient in handling large volumes of content, and allows OmniMark to outperform its competitor technologies whenever the data volume is high." Not bad for a technology now decades old,and the BOD are now able to advance its use via Migrate and AuthorBridge. At the AGM a couple of weeks ago it was mentioned that Migrate revenues would more or less double in the current year(adding £300k++ to revenues.Omnimark engagements are also projected to revive,whilst AuthorBridge is expected to provide its maiden contribution. If IBM take on AuthorBridge at enterprise level,as seems very likely,then STL is going to become a hugely exciting investment. It currently comprises 100% of my portfolio.

If Stilo were to pull off the enterprise level AuthorBridge engagement with IBM(worth £500k p.a.) and Migrate revenues keep climbing(forecast to reach £700k this year),whilst at the same time revitalising Omnimark (underway),then I believe tat your target figure of 8-10p,polarhare,will be well and truly breached within 12 months.

http://www.businessgreen.com/bg/news/2405056/biome-bioplastic-sets-sights-on-industrial-scale-green-plastic-production A leading developer of emerging bioplastic technologies has revealed plans for a new £3m research programme designed to accelerate the commercial development of plastics made from waste organic material. Biome Bioplastics has been responsible for a series of breakthroughs in the fledgling bioplastic market, developing the first compostable coffee pods and demonstrating how bioplastics could play key role in the emerging 3D printing sector. FURTHER READING As the election rumbles on, clean tech start ups are getting on with it ArcelorMittal steels itself for revamped green push The company will today announce plans for the next phase of its research and development, in the form of a three year work programme backed by Innovate UK, the Biotechnology and Biological Sciences Research Council (BBSRC) and the Engineering and Physical Sciences Research Council (EPSRC), among others. The project will see the company work with teams at the universities of Warwick, Liverpool and Leeds as well as the Centre for Process Innovation (CPI) on Teesside to explore how bio-based chemicals derived from lignin could be produced at an industrial scale. Lignin is an abundant waste product from the pulp and paper industry that Biome Bioplastics believes can be harnessed to produce sustainable chemicals that could then be used in the production of bioplastics, as well as fragrances, coatings and personal care products. "The ready availability of high value, sustainable chemicals from natural sources will be a game changer for the bioplastics market," said Biome Bioplastics chief executive Paul Mines in a statement. "Success in this work would allow us to competitively challenge the dominance of oil-based polymers. The technology we are developing is part of the growing adoption of bio-based processes that is likely to deliver radical changes across the materials industry." The project will build on work undertaken by Biome Bioplastics and the University of Warwick's Centre for Industrial Biotechnology and Biorefining, which successfully demonstrated that bacterial degradation can be used to produce organic chemicals from lignin that are suitable for bioplastic manufacture. The project will now aim to replicate the results at scale in a bid to prove that the process could support commercially viable bioplastic production. Growing numbers of retailers have turned to bioplastic technologies as a means of cutting the environmental impact of conventional plastics found in packaging and plastic bags. However, the sector has been hampered by concerns over costs and fears that using crops to produce bioplastics can erode food supplies. Thanks to JMF69 over on ADVFN

More of a tragedy in my opinion, but entertaining nevertheless .

On all measurements,Stilo's second half performance bettered that of its first six months(which were admittedly very disappointing). Extracting the significant NEW corporate clients for StiloMigrate added in their second half we have:- ANSYS SAP INTEL ATMEL VESTAS. In addition,NATIONAL GEOSPACIAL became a NEW Omnimark client. As revenues from StiloMigrate become more meaningful,the auditors will hopefully differentiate between the various revenue streams in order to provide investors with a clearer picture of divisional progress. With revenues attributable to Migrate possible equating to around £40k in prior six month tradingperiods,it looks as though these jumped to around £80k in the second half of 2014. A continuance of this trend would augur very well for 2015.The AGM statement might provide further clarity.

I believe that STL will outperform at least 95% of the shares on AIM over the coming one to five years.We are already seeing exponential growth in Migrate usage;shortly to be backed up by AuthorBridge,which the BOD class as a potentially disruptive technology and from which they predict "significant revenues".Omnimark revenues will revert quickly to more normal levels serving to generate a confluence of rising profitability. David Ashman's recent purchase of 3,002,000 Stilo shares is undoubtedly an expression of great confidence in the future of this superb,albeit currently slow burning,micro-cap.